Osteoarthritis guidelines:A progressive role for topical nonsteroidal anti-inflammatory drugs

Journal of Multidisciplinary Healthcare

Volumn 6, Issue , 2013, Pages 133-137

  Stanos, Steven P ^a  

^a REHABILITATION INSTITUTE OF CHICAGO   (United States)

Author keywords

Diclofenac; Guidelines; Nonsteroidal anti inflammatory drugs; Osteoarthritis; Topical analgesics

Indexed keywords

ANALGESIC AGENT; CORTICOSTEROID; DICLOFENAC; LIDOCAINE; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PLACEBO;

ABDOMINAL PAIN; ARTICLE; CHRONIC PAIN; DIARRHEA; DISEASE ASSOCIATION; DOSE RESPONSE; DRUG DOSAGE FORM COMPARISON; DRUG FORMULATION; DRUG SAFETY; EVIDENCE BASED MEDICINE; HAND OSTEOARTHRITIS; HEALTH CARE ORGANIZATION; HUMAN; KNEE OSTEOARTHRITIS; MEDICAL SOCIETY; NAUSEA; OSTEOARTHRITIS; PAIN; PATIENT CARE; PRACTICE GUIDELINE; RISK FACTOR; TREATMENT INDICATION; UNSPECIFIED SIDE EFFECT;

EID: 84876147658     PISSN: None     EISSN: 11782390     Source Type: Journal    
DOI: 10.2147/JMDH.S35229     Document Type: Article

References (27)

1. Lawrence RC, Felson DT, Helmick CG, et al. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States.Part II. Arthritis Rheum. 2008;58(1):26-35.
2. Kotlarz H, Gunnarsson CL, Fang H, Rizzo JA. Insurer and out-of-pocket costs of osteoarthritis in the US: evidence from national survey data. Arthritis Rheum. 2009;60(12):3546-3553.
3. Centers for Disease Control and Prevention. August 27, 2007. Arthritis types: osteoarthritis. Available from: http://www.cdc.gov/arthritis/ basics/osteoarthritis.htm. Accessed August 24, 2011.
4. Centers for Disease Control and Prevention. Prevalence of doctordiagnosed arthritis and arthritis-attributable activity limitation - United States, 2007-2009. MMWR Morb Mortal Wkly Rep. 2010;59(39):1261-1265.
5. Felson DT. Developments in the clinical understanding of osteoarthritis. Arthritis Res Ther. 2009;11(1):203.
6. Altman RD. New guidelines for topical NSAIDs in the osteoarthritis treatment paradigm. Curr Med Res Opin. 2010;26(12):2871-2876.
7. Barkin RL, Beckerman M, Blum SL, Clark FM, Koh EK, Wu DS. Should nonsteroidal anti-inflammatory drugs (NSAIDs) be prescribed to the older adult? Drugs Aging. 2010;27(10):775-789.
8. American Academy of Orthopaedic Surgeons. Treatment of Osteoarthritis of the Knee (Non-Arthroplasty). Rosemont, IL: American Academy of Orthopaedic Surgeons; 2008.
9. National Collaborating Centre for Chronic Conditions. Osteoarthritis: National Clinical Guideline for Care and Management in Adults. London: Royal College of Physicians; 2008. Available from: http://www.nice.org.uk/nicemedia/pdf/CG059FullGuideline.pdf. Accessed July 18, 2011.
10. Hochberg MC, Altman RD, April KT, et al. American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee. Arthritis Care Res (Hoboken). 2012;64(4):465-474.
11. Makris UE, Kohler MJ, Fraenkel L. Adverse effects of topical nonsteroidal antiinflammatory drugs in older adults with osteoarthritis: a systematic literature review. J Rheumatol. 2010;37(6):1236-1243.
12. Carnes D, Anwer Y, Underwood M, Harding G, Parsons S. Influences on older people's decision making regarding choice of topical or oral NSAIDs for knee pain: qualitative study. BMJ. 2008; 336(7636):142-145.
13. Voltaren ® Gel (diclofenac sodium topical gel) 1% [prescribing information]. Chadds Ford, PA: Endo Pharmaceuticals Inc; 2009.
14. Barthel HR, Haselwood D, Longley S 3rd, Gold MS, Altman RD. Randomized controlled trial of diclofenac sodium gel in knee osteoarthritis. Semin Arthritis Rheum. 2009;39(3):203-212.
15. Niethard FU, Gold MS, Solomon GS, et al. Efficacy of topical diclofenac diethylamine gel in osteoarthritis of the knee. J Rheumatol. 2005;32(12):2384-2392.
16. Baraf HS, Gloth FM, Barthel HR, Gold MS, Altman RD. Safety and efficacy of topical diclofenac sodium gel for knee osteoarthritis in elderly and younger patients: pooled data from three randomized, double-blind, parallel-group, placebo-controlled, multicentre trials. Drugs Aging. 2011;28(1):27-40.
17. Pennsaid® (diclofenac sodium topical solution) 1.5% w/w [prescribing information]. Hazelwood, MO: Mallinckrodt Brand Pharmaceuticals, Inc; 2010.
18. Baer PA, Thomas LM, Shainhouse Z. Treatment of osteoarthritis of the knee with a topical diclofenac solution: a randomised controlled, 6-week trial [ISRCTN53366886]. BMC Musculoskelet Disord. 2005;6:44.
19. Bookman AA, Williams KS, Shainhouse JZ. Effect of a topical diclofenac solution for relieving symptoms of primary osteoarthritis of the knee: a randomized controlled trial. CMAJ. 2004;171(4):333-338.
20. Roth SH, Shainhouse JZ. Efficacy and safety of a topical diclofenac solution (Pennsaid) in the treatment of primary osteoarthritis of the knee: a randomized, double-blind, vehicle-controlled clinical trial. Arch Intern Med. 2004;164(18):2017-2023.
21. Simon LS, Grierson LM, Naseer Z, Bookman AA, Shainhouse JZ. Efficacy and safety of topical diclofenac containing dimethyl sulfoxide (DMSO) compared with those of topical placebo, DMSO vehicle and oral diclofenac for knee osteoarthritis. Pain. 2009;143(3): 238-245.
22. Tugwell PS, Wells GA, Shainhouse JZ. Equivalence study of a topical diclofenac solution (Pennsaid) compared with oral diclofenac in symptomatic treatment of osteoarthritis of the knee: a randomized controlled trial. J Rheumatol. 2004;31(10):2002-2012.
23. Roth SH, Fuller P. Diclofenac sodium topical solution 1.5% w/w with dimethyl sulfoxide compared with placebo for the treatment of osteoarthritis: pooled safety results. Postgrad Med. 2011;123(6):180-188.
24. Lidoderm ® (lidocaine patch 5%) [prescribing information]. Chadds Ford, PA: Endo Pharmaceuticals Inc; 2010.
25. Gammaitoni AR, Galer BS, Onawola R, Jensen MP, Argoff CE. Lidocaine patch 5% and its positive impact on pain qualities in osteoarthritis: results of a pilot 2-week, open-label study using the Neuropathic Pain Scale. Curr Med Res Opin. 2004;20(Suppl 2):S13-S19.
26. Brabant T, Stichtenoth D. Pharmacological treatment of osteoarthritis in the elderly. Z Rheumatol. 2005;64(7):467-472. German.
27. Altman RD, Barthel HR. Topical therapies for osteoarthritis. Drugs. 2011;71(10):1259-1279.